Article
Integrative Transcriptomics and Machine Learning Reveal a Robust Biomarker Signature for Alzheimer’s Disease
2026-05-29
Abstract excerpt
<title>Abstract</title> <p>Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and complex molecular alterations involving immune activation, synaptic dysfunction, and metabolic imbalance. Despite extensive research, robust and biologically interpretable transcriptomic signatures capable of reliably distinguishing AD from cognitively normal controls...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7f979d69-f5c9-5815-a450-bed40c40cb32
- DOI
- 10.21203/rs.3.rs-9839534/v1
